New Delhi: Drug major Sun Pharmaceutical Industries said it has launched Kapspargo Sprinkle (metoprolol succinate) extended-release capsules used for the treatment of hypertension, chest pain and heart failure in the US market.
Kapspargo Sprinkle pellets can be sprinkled over soft food or administered via a nasogastric tube, and are designed to facilitate long-term, once-daily administration, particularly for patients who have difficulty swallowing, Sun Pharma said in a BSE filing.
Sun Pharma North America CEO Abhay Gandhi said: “Kapspargo Sprinkle capsules may make it easier for patients to take their antihypertensive medication.”
Ruby Khatun joined Medical Dialogue as Reporter in 2016. She covers all the business news in different categories. She also covers all the updates in Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a post graduate from Jamia Hamdard. She can be contacted at email@example.com Contact no. 011-43720751